Prexton Therapeutics develops novel therapeutic compounds for the treatment of brain disorders and CNS diseases.
Business Model:
Revenue: $1M
Employees: 201-500
Prexton Therapeutics was acquired by
Lundbeck.
The acquisition happend on 2018-03-16.
Details of the transaction were not public
Address: Kloosterstraat 9
City: Oss
State: noord-brabant
Zip: 5349 AB
Country: NL
Prexton Therapeutics develops novel therapeutic compounds for the treatment of brain disorders and CNS diseases.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2018 | Series B | $31.6M |
Forbion Capital Partners Seroba Life Sciences Merck Ventures Ysios Capital Sunstone Capital |
2/2017 | Series B | $31.2M |
Forbion Capital Partners Seroba Life Sciences Merck Ventures Ysios Capital Sunstone Capital |
2/2017 | Series B | 5 | $31.1M |
Ysios Capital M Ventures Forbion Capital Partners Sunstone Life Science Ventures Seroba Life Sciences Forbion Capital Partners Seroba Life Sciences Ysios Capital M Ventures Forbion Capital Partners Sunstone Life Science Ventures Seroba Life Sciences Forbion Capital Partners Seroba Life Sciences |
1/2013 | Seed Round | 1 | - |
Eclosion SA Eclosion SA Eclosion SA Eclosion SA |
2/2015 | Series A | 3 | $10M |
Sunstone Life Science Ventures Ysios Capital M Ventures Ysios Capital Sunstone Life Science Ventures Ysios Capital M Ventures Ysios Capital |
1/2013 | Seed Round | 1 | - |
Eclosion SA Eclosion SA Eclosion SA Eclosion SA |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|